ARCHIVES

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

Cancer Program Advocate Mary Lasker, 93, Prodded Government, Scientists For Cures

March 4, 1994

NCI-Approved Clinical Trials

August 31, 2001

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

HCFA Abadons Plan To Cut Cancer Drug Payments.

September 15, 2000